Table 3.

Disease-free survival for breast cancer subgroups

Population subgroup (n)	Cumulative DFS* (mo)
ER+ all (168)	82% DFS (107)
ER+/BRMS1+ (128)	83% DFS (107)
ER+/BRMS1− (40)	80% DFS (88)
ER− all (43)	58% DFS (105)
ER−/BRMS1+ (28)	59% DFS (105)
ER−/BRMS1− (15)†	53% DFS (104)
PR+ all (130)	81% DFS (107)
PR+/BRMS1+ (104)	79% DFS (107)
PR+/BRMS1− (26)	88% DFS (87)
PR− all (81)	69% DFS (104)
PR−/BRMS1+ (52)	75% DFS (93)
PR−/BRMS1− (29)	59% DFS (104)
HER2+ all (24)	57% DFS (105)
HER2+/BRMS1+ (13)	61% DFS (105)
HER2+/BRMS1− (11)	53% DFS (88)
HER2− all (188)	79% DFS (107)
HER2−/BRMS1+ (144)	80% DFS (107)
HER2−/BRMS1− (44)	78% DFS (104)

NOTE: Survival data were available for 212 cases. ER and PR staining data were available on 211 of these cases.

^*DFS, disease-free survival.

^†The lowest DFS for ER, PR, or HER2 is shown in boldface.